Related Experiment Video
Updated: Jun 12, 2026

08:08
Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
A functional placenta-on-chip model for maternal-fetal transport
Anshul Bhide1, Sourav Mukherjee2, Kinjalka Ghosh3
1Molecular and Cellular Biology Laboratory, ICMR National Institute for Research on Women's Health (ICMR-NIRWoH); (Formerly ICMR-NIRRCH), Mumbai 400012, India.
Biofabrication
|June 10, 2026
Summary
Researchers developed a novel placenta-on-a-chip model to study human placental barrier function. This accessible platform accurately mimics placental transport and metabolic regulation, aiding research into pregnancy complications and drug safety.
Area of Science:
- Obstetrics and Gynecology
- Biomedical Engineering
- Developmental Biology
Background:
- The human placenta is a complex barrier crucial for fetal development, but studying its function is challenging due to limited tissue access and complex in vitro models.
- Existing models often fail to fully recapitulate the structural and functional intricacies of the in vivo human placental barrier.
Purpose of the Study:
- To develop and validate a static, two-chamber placenta-on-a-chip platform that recreates key attributes of the human placental barrier.
- To provide an experimentally accessible model for investigating placental transport, metabolic regulation, and barrier integrity.
Main Methods:
- A two-chamber device separated by a microporous membrane coated with extracellular matrix was designed.
- The platform was engineered to support trophoblast syncytialization, hormone secretion, and selective barrier function.
- Experiments assessed macromolecular restriction, small solute diffusion, glucose transport, urea exchange, and response to hyperglycemic conditions.
Main Results:
- The engineered placental barrier restricted macromolecular transport while allowing controlled diffusion of small solutes.
- Glucose transport was sensitive to cellular configuration and endothelial layer presence, yielding in vivo-comparable fetal-to-maternal ratios.
- The platform demonstrated directional urea transfer and increased glucose transport under hyperglycemia without barrier breakdown.
Conclusions:
- The developed placenta-on-a-chip platform offers a scalable and robust model for studying placental barrier function, transport, and metabolism.
- This model provides a valuable tool for advancing research in placental biology, pregnancy-associated pathologies, and the safety assessment of drugs during pregnancy.

